Logo Logo

Publications by Sebastian, Stintzing

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Jump to: 2017
Number of items: 2.

2017

Dominik, Modest; Ludwig, Fischer von Weikersthal; Thomas, Decker; Ursula, Vehling-Kaiser; Jens, Uhlig; Michael, Schenk; Jens, Freiberg-Richter; Bettina, Peuser; Claudio, Denzlinger; Christina, Peveling Genannt Reddemann; Ullrich, Graeven; Gunter, Schuch; Ingo, Schwaner; Arndt, Stahler; Andreas, Jung; Swantje, Held; Sebastian, Stintzing; Clemens, Giessen-Jung; Volker, Heinemann (2017): Randomized phase III study of fluoropyrimidine (FP) plus bevacizumab (BEV) vs. FP plus irinotecan (IRI) and BEV as first-line therapy for metastatic colorectal cancer (mCRC): German AIO KRK0110 (ML22011)- study. In: Annals of Oncology, Vol. 28

Dominik, Modest P.; Timm, Denecke; Johann, Pratschke; Hauke, Lang; Marc, Bemelmans; Thomas, Becker; Markus, Rentsch; Daniel, Seehofer; Christiane, Bruns J.; Bernhard, Gebauer; Sebastian, Stintzing; Heike, Modest; Swantie, Held; Gunnar, Folprecht; Volker, Heinemann; Ulf, Neumann P. (2017): Central evaluation for surgical treatment options in FIRE-3-updated results and impact on overall Survival. In: Annals of Oncology, Vol. 28

This list was generated on Tue Jul 5 02:34:48 2022 CEST.